U.S. Consumer Durables Stock News

If you are wondering whether Dynavax Technologies is quietly turning into a value opportunity or just another biotech rollercoaster, you are in the right place. The stock has slipped about 4% over the last week but is still up roughly 9.2% over the past month, even though it remains down around 15.0% year to date and 14.5% over the last year, after a strong 140.0% gain over five years. Recent attention has centered on Dynavax's expanding role in vaccine adjuvants and partnerships that aim to...

If you are wondering whether Nutanix at around $47 a share is a bargain in disguise or a value trap waiting to happen, this breakdown is for you. The stock has slid about 33.3% over the last month and is down 22.6% year to date, yet it is still sitting on gains of roughly 57.4% over 3 years and 59.6% over 5 years. That kind of whiplash in returns has coincided with shifting sentiment around high growth software names, as investors rotate between riskier cloud stories and more predictable...

TETRA Technologies recently announced it signed a term sheet to form a joint venture with Magrathea Metals to integrate electrolytic magnesium production into its Evergreen Project in Southwest Arkansas, which is expected to produce 75 million pounds of bromine annually and recover other critical minerals like lithium and magnesium. This collaboration aims to help rebuild the U.S. magnesium metal defense industrial base using brine-based resources, potentially broadening TETRA’s role in...

If you are wondering whether Dutch Bros at around $61 a share is a caffeine fueled bargain or just pricey buzz, this article is for you. We are going to unpack what the current market price really implies about its future. The stock has quietly kept the momentum going, up about 5% over the last week, 12.3% over the past month, and roughly 12.9% over the last year, compounding into an 87.2% gain over three years. Behind those moves, Dutch Bros has been steadily expanding its store footprint...

CureVac (NasdaqGM:CVAC) has just been dropped from the NASDAQ Biotechnology Index, a mechanical change that can still matter for investors as index tracking funds trim positions and liquidity dynamics start to shift. See our latest analysis for CureVac. That index removal lands after a busy stretch for CureVac, including new board appointments and mixed earnings. It also comes at a time when the share price has climbed sharply year to date, although longer term total shareholder returns still...

Global Ship Lease (NYSE:GSL) is leaning into its fleet renewal strategy by agreeing to buy three Korean built 8,600 TEU containerships with ECO upgrades and long term charters attached for $90 million. See our latest analysis for Global Ship Lease. That strategy is landing against a strong backdrop, with the share price up 14.4 percent over the past month and delivering a 73.6 percent total shareholder return over the last year. This suggests momentum is building as earnings and fleet moves...

IDEXX Laboratories recently reported its third-quarter 2025 results, posting earnings per share of $3.40, a 21.4% increase year over year, and raised its full-year 2025 outlook for both revenue and earnings growth. The strong performance was powered by robust expansion in the Companion Animal Group and Livestock, Poultry and Dairy segments, highlighting the growing importance of recurring diagnostics and testing services in IDEXX’s global portfolio. With IDEXX lifting full-year guidance on...

Absci (ABSI) just crossed an important milestone by dosing the first healthy volunteers in its Phase 1/2a HeadLINE trial for ABS-201, an AI designed antibody targeting androgenetic alopecia and, later, endometriosis. See our latest analysis for Absci. The ABS-201 milestone lands after a volatile stretch, with the share price up 8.6 percent over one day and 6.5 percent over seven days, yet still showing a negative 30 day share price return while the 1 year total shareholder return remains...

If you are wondering whether Science Applications International is quietly turning into a value opportunity after a rough stretch in the market, you are not alone. This is exactly what we are going to unpack. The stock now trades around $87.53, up 2.1% over the last week but still down 4.2% over 30 days and 22.0% year to date, reflecting a market that has cooled on the name after a longer 1 year slide of 28.4%. In recent months, investor attention has been shaped more by shifting sentiment...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

As the Dow Jones and S&P 500 approach record highs, buoyed by expectations of a potential Federal Reserve rate cut, the U.S. tech sector remains a focal point for investors navigating an evolving economic landscape marked by mixed employment data and fluctuating Treasury yields. In such a dynamic environment, identifying high-growth tech stocks involves assessing factors like innovation potential, market positioning, and adaptability to macroeconomic shifts that can influence performance in...

As the Dow Jones and S&P 500 approach record highs, investors are closely watching market movements amidst expectations of a potential interest rate cut by the Federal Reserve. In this environment, identifying stocks that may be trading below their intrinsic value can offer opportunities for those seeking to capitalize on market inefficiencies.

As the Dow Jones and S&P 500 approach record highs, investors are keeping a close eye on market movements and potential interest rate cuts by the Federal Reserve. Investing in penny stocks—though a somewhat outdated term—remains relevant as these stocks often represent smaller or newer companies that can offer unique growth opportunities. By focusing on those with strong financials, investors may uncover hidden gems poised for long-term success amidst current market conditions.

You may think that with a price-to-sales (or "P/S") ratio of 9.6x Clearwater Analytics Holdings, Inc. ( NYSE:CWAN ) is...

In December 2025, Black Stone Minerals, L.P. announced it had entered into a multi-year development agreement with an affiliate of Caturus Energy, covering 220,000 gross acres in the Shelby Trough and Haynesville Expansion to support growing Gulf Coast natural gas demand. The deal outlines a structured ramp-up from pilot wells in the first two years to about 12 gross wells annually by year six, potentially unlocking more value from Black Stone’s roughly 40,000 undeveloped net acres in the...

Axsome Therapeutics (AXSM) just followed up a 63% year over year revenue jump with plans to showcase its growth story at the Piper Sandler Healthcare Conference, putting Auvelity, Sunosi and new migraine drug Symbravo firmly in the spotlight. See our latest analysis for Axsome Therapeutics. That growth narrative is increasingly reflected in the market, with Axsome’s share price at $147.81 and a roughly 69% year to date share price return pointing to building momentum. The three year total...

Camtek (CAMT) is back on many radar screens after Morgan Stanley initiated coverage, alongside a wave of rating upgrades from other brokerages, a cluster of fresh opinions that often nudges sentiment and trading activity. See our latest analysis for Camtek. That growing analyst enthusiasm has arrived on the back of strong momentum, with the share price at $116.93 after a 5.44% 1 day share price return and a standout 48.48% 90 day share price return. The 5 year total shareholder return of...

Ramaco Resources (METC) has scheduled a special call to discuss developments in U.S. critical minerals and its Brook Mine project, a move that hints at meaningful strategic updates for the company’s long term growth mix. See our latest analysis for Ramaco Resources. Investors seem to be reassessing Ramaco’s growth story, with the recent U.S. critical minerals push coming after a sharp setback in its 30 day share price return of minus 36.52 percent. Even so, the year to date share price return...

In the past quarter, Yext reported annual recurring revenue growth of 9.1% year-on-year alongside a worsening operating margin, highlighting rising cost pressures and competitive headwinds. A negative customer acquisition cost payback period underscored that recent sales and marketing spending has yet to convert into sustainable, profitable growth. We’ll now explore how Yext’s modest recurring revenue growth and weak customer acquisition efficiency may reshape its broader investment...

In early December 2025, Wolfspeed, Inc. reported receiving a US$698.6 million cash tax refund from the IRS under the Advanced Manufacturing Investment Credit, boosting liquidity as it ramps its 200mm silicon carbide manufacturing footprint and earmarks funds to retire about US$175 million of debt. This refund is particularly important because Wolfspeed only recently emerged from Chapter 11 bankruptcy and continues to contend with ongoing cash burn and financial pressure while expanding into...

Navient (NAVI) has been treading water lately, with the stock flat over the past day but up about 5% this month after a weaker past 3 months and year. Investors are weighing improving revenue against ongoing losses. See our latest analysis for Navient. That recent 5% one month share price return comes after a softer stretch, leaving the stock down on a year to date basis while the one year total shareholder return remains negative, which suggests any momentum is still rebuilding rather than...

In November 2025, Domino’s Pizza announced the immediate resignation of board member C. Andrew Ballard and confirmed earlier news of the UK CEO’s departure amid a supply glut and tough conditions in the British pizza market, while reiterating that Ballard’s exit was not due to any disagreement with company practices. At the same time, management highlighted profit growth slightly ahead of expectations and confidence in taking market share despite macro and industry pressures, raising...

Zions Bancorporation National Association (ZION) has been quietly grinding higher, with the stock up about 1 % today, nearly 3 % over the past week, and roughly 6 % this month. See our latest analysis for Zions Bancorporation National Association. At around $54.82 per share, Zions’ recent 1 month share price return of nearly 6% contrasts with a slightly negative 1 year total shareholder return, suggesting short term momentum is improving even as longer term gains remain more modest. If Zions...

IQVIA Holdings (IQV) just posted quarterly results that cleared the bar on both revenue and earnings, with organic growth and helpful currency shifts pushing sales up 5.2% and adjusted EPS up 6% year over year. See our latest analysis for IQVIA Holdings. Those solid quarterly beats come on top of a strong run, with IQVIA’s share price up a robust 23.45% over the past three months and its 11.85% one year total shareholder return pointing to gradually improving sentiment rather than euphoric...